Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hannaman

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Expert Review of Vaccines|May 11, 2010
Electroporation for DNA immunization: clinical applicationSylvia van Drunen Littel-van den Hurk, D Hannaman
Vaccine|September 6, 2005
Enhancement of immune responses to an HBV DNA vaccine by electroporationA Luxembourg, D Hannaman, B Ellefsen, et al.
Vaccine|March 9, 2010
Codon-optimization of the hemagglutinin gene from the novel swine origin H1N1 influenza virus has differential effects on CD4(+) T-cell responses and immune effector mechanisms following DNA electroporation in miceM Tenbusch, T Grunwald, T Niezold, et al.
Vaccine|May 9, 2008
Potentiation of an anthrax DNA vaccine with electroporationA Luxembourg, D Hannaman, E Nolan, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 23, 2014
A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporationJ W Hooper, J E Moon, K M Paolino, et al.
Vaccine|August 19, 2008
Electroporation-based DNA transfer enhances gene expression and immune responses to DNA vaccines in cattleS van Drunen Littel-van den Hurk, A Luxembourg, B Ellefsen, et al.
Antiviral Research|February 15, 2012
A DNA vaccination regime including protein boost and electroporation protects cattle against foot-and-mouth diseaseV Fowler, L Robinson, B Bankowski, et al.
Vaccines|July 16, 2020
A Phase 2a Randomized, Double-Blind, Dose-Optimizing Study to Evaluate the Immunogenicity and Safety of a Bivalent DNA Vaccine for Hemorrhagic Fever with Renal Syndrome Delivered by Intramuscular ElectroporationJay Hooper, K M Paolino, K Mills, et al.
Scientific Reports|October 14, 2017
Combined skin and muscle vaccination differentially impact the quality of effector T cell functions: the CUTHIVAC-001 randomized trialG Haidari, A Cope, A Miller, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Expert Review of Vaccines|May 11, 2010
Electroporation for DNA immunization: clinical applicationSylvia van Drunen Littel-van den Hurk, D Hannaman
Vaccine|September 6, 2005
Enhancement of immune responses to an HBV DNA vaccine by electroporationA Luxembourg, D Hannaman, B Ellefsen, et al.
Vaccine|March 9, 2010
Codon-optimization of the hemagglutinin gene from the novel swine origin H1N1 influenza virus has differential effects on CD4(+) T-cell responses and immune effector mechanisms following DNA electroporation in miceM Tenbusch, T Grunwald, T Niezold, et al.
Vaccine|May 9, 2008
Potentiation of an anthrax DNA vaccine with electroporationA Luxembourg, D Hannaman, E Nolan, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 23, 2014
A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporationJ W Hooper, J E Moon, K M Paolino, et al.
Vaccine|August 19, 2008
Electroporation-based DNA transfer enhances gene expression and immune responses to DNA vaccines in cattleS van Drunen Littel-van den Hurk, A Luxembourg, B Ellefsen, et al.
Antiviral Research|February 15, 2012
A DNA vaccination regime including protein boost and electroporation protects cattle against foot-and-mouth diseaseV Fowler, L Robinson, B Bankowski, et al.
Vaccines|July 16, 2020
A Phase 2a Randomized, Double-Blind, Dose-Optimizing Study to Evaluate the Immunogenicity and Safety of a Bivalent DNA Vaccine for Hemorrhagic Fever with Renal Syndrome Delivered by Intramuscular ElectroporationJay Hooper, K M Paolino, K Mills, et al.
Scientific Reports|October 14, 2017
Combined skin and muscle vaccination differentially impact the quality of effector T cell functions: the CUTHIVAC-001 randomized trialG Haidari, A Cope, A Miller, et al.
Pageof 1